Events

News

Breakthrough ALS Treatment Approved in Japan: Mecoba

Neurologist Dr. Lawrence Wong recommends that ApoE4 gene testing be performed before starting new Alzheimer's drug treatment to assess the risk of brain edema/brain microbleeding [Reprinted from Sing Tao.com]

AKEEGA™ receives U.S. FDA Approval for BRCA-Induced Metastatic Castration-Resistant Prostate Cancer (mCRPA)

Exciting Sponsorship Programs for NSCLC and Solid Tumor Patients

Guardant Health’s Shield™ Blood Test Approved by FDA

[Bowtie網誌] 傳統癌症指數已過時？了解追蹤癌症治療成效的新指標！

Successful Recruitment Talk at HKUST

Codex will participate in Best of ASCO 2024, Hong Kong

Codex’s Co-founders sharing insights on genetic testing at Metro Broadcast

Codex participated in the Cancer 2024 Cancer Immunology Conference

[HOY TV Health Focus] Codex was recently invited to introduce our liquid biopsy test for detecting early-stage breast cancer recurrence on the HOY TV Health Focus TV show | Guardant Reveal | Cancer Liquid Biopsy

Codex Annual Oncology Roundtable: Tackling Minimal Residual Disease and Complex Mutations

Participate in the 15th Hong Kong International Medical and Healthcare Exhibition

香港電台#Hashtag Hong Kong：陳浩然教授專訪